DK1117392T3 - Fremgangsmåde til forhindring eller forsinkelse af kateterbaseret revaskularisation - Google Patents

Fremgangsmåde til forhindring eller forsinkelse af kateterbaseret revaskularisation

Info

Publication number
DK1117392T3
DK1117392T3 DK99933763T DK99933763T DK1117392T3 DK 1117392 T3 DK1117392 T3 DK 1117392T3 DK 99933763 T DK99933763 T DK 99933763T DK 99933763 T DK99933763 T DK 99933763T DK 1117392 T3 DK1117392 T3 DK 1117392T3
Authority
DK
Denmark
Prior art keywords
procedure
preventing
based revascularization
delaying
catheter
Prior art date
Application number
DK99933763T
Other languages
Danish (da)
English (en)
Inventor
Donald Michael Black
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22289955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1117392(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1117392T3 publication Critical patent/DK1117392T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DK99933763T 1998-09-30 1999-07-08 Fremgangsmåde til forhindring eller forsinkelse af kateterbaseret revaskularisation DK1117392T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10245798P 1998-09-30 1998-09-30

Publications (1)

Publication Number Publication Date
DK1117392T3 true DK1117392T3 (da) 2004-06-14

Family

ID=22289955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99933763T DK1117392T3 (da) 1998-09-30 1999-07-08 Fremgangsmåde til forhindring eller forsinkelse af kateterbaseret revaskularisation

Country Status (35)

Country Link
US (1) US20080119561A1 (sh)
EP (1) EP1117392B1 (sh)
JP (1) JP2002525321A (sh)
KR (1) KR20010079955A (sh)
CN (1) CN1197565C (sh)
AP (1) AP1708A (sh)
AT (1) ATE260100T1 (sh)
AU (1) AU768474B2 (sh)
BG (1) BG105471A (sh)
BR (1) BR9914098A (sh)
CA (1) CA2343299C (sh)
CZ (1) CZ20011035A3 (sh)
DE (1) DE69915084T2 (sh)
DK (1) DK1117392T3 (sh)
EA (1) EA007427B1 (sh)
EE (1) EE200100199A (sh)
ES (1) ES2214872T3 (sh)
HK (1) HK1042436A1 (sh)
HR (1) HRP20010236A2 (sh)
HU (1) HUP0103648A3 (sh)
ID (1) ID30255A (sh)
IL (2) IL141953A0 (sh)
IS (1) IS5889A (sh)
NO (1) NO20011615L (sh)
NZ (1) NZ510500A (sh)
OA (1) OA11787A (sh)
PL (1) PL346980A1 (sh)
PT (1) PT1117392E (sh)
SI (1) SI1117392T1 (sh)
SK (1) SK4122001A3 (sh)
TR (1) TR200100901T2 (sh)
UA (1) UA73292C2 (sh)
WO (1) WO2000018395A1 (sh)
YU (1) YU23901A (sh)
ZA (1) ZA200102230B (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
CA2414783A1 (en) * 2000-07-14 2002-01-24 Warner-Lambert Company Treatment of eating disorders using carboxyalkylethers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
US5807388A (en) * 1994-05-25 1998-09-15 The Trustees Of Columbia University In The City Of New York Myocardial revascularization through the endocardial surface using a laser
WO1995013063A1 (en) * 1993-11-09 1995-05-18 Merck & Co., Inc. HMG-CoA REDUCTASE INHIBITORS IN THE NORMALIZATION OF VASCULAR ENDOTHELIAL DYSFUNCTION
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
AU720853B2 (en) * 1995-11-02 2000-06-15 Warner-Lambert Company Method and pharmaceutical composition for regulating lipid concentration
SE506272C2 (sv) * 1996-03-18 1997-11-24 Paul Edholm Förfarande och anordning för att bestämma bildläge och bildvinkel i en röntgenbild
IL117702A0 (en) * 1996-03-28 1996-07-23 Tel Aviv Medical Center Resear Drug for hyperlipoproteinemia
WO1998001100A2 (en) * 1996-07-09 1998-01-15 Merck & Co., Inc. Method for treating homozygous familial hypercholesterolemia
US5861399A (en) * 1996-07-17 1999-01-19 Heart Care Partners Methods and compositions for the rapid and enduring relief of inadequate myocardial function
US6180660B1 (en) * 1997-08-26 2001-01-30 Merck & Co., Inc. Cholesterol-lowering therapy
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
CA2343299A1 (en) 2000-04-06
EP1117392A1 (en) 2001-07-25
OA11787A (en) 2005-07-26
EE200100199A (et) 2002-06-17
NO20011615L (no) 2001-04-24
AU768474B2 (en) 2003-12-11
BR9914098A (pt) 2001-07-31
CA2343299C (en) 2008-04-01
ES2214872T3 (es) 2004-09-16
HUP0103648A3 (en) 2003-10-28
US20080119561A1 (en) 2008-05-22
HRP20010236A2 (en) 2002-04-30
UA73292C2 (en) 2005-07-15
PT1117392E (pt) 2004-07-30
IL141953A0 (en) 2002-03-10
ID30255A (id) 2001-11-15
HK1042436A1 (en) 2002-08-16
EP1117392B1 (en) 2004-02-25
SK4122001A3 (en) 2002-06-04
HUP0103648A2 (hu) 2003-08-28
SI1117392T1 (en) 2004-06-30
EA200100370A1 (ru) 2001-10-22
AU4975099A (en) 2000-04-17
YU23901A (sh) 2003-07-07
DE69915084T2 (de) 2004-07-22
WO2000018395A1 (en) 2000-04-06
TR200100901T2 (tr) 2001-08-21
CZ20011035A3 (cs) 2001-10-17
AP2001002112A0 (en) 2001-06-30
NO20011615D0 (no) 2001-03-29
PL346980A1 (en) 2002-03-11
EA007427B1 (ru) 2006-10-27
DE69915084D1 (de) 2004-04-01
BG105471A (en) 2001-12-31
IL141953A (en) 2006-07-05
ZA200102230B (en) 2002-06-18
KR20010079955A (ko) 2001-08-22
CN1342072A (zh) 2002-03-27
JP2002525321A (ja) 2002-08-13
CN1197565C (zh) 2005-04-20
NZ510500A (en) 2003-10-31
IS5889A (is) 2001-03-14
AP1708A (en) 2007-01-10
ATE260100T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
DE59907926D1 (de) Turbinenschaufel
DE59905944D1 (de) Turbinenschaufel
DE69916360D1 (de) Flügelprofil
DE69938817D1 (de) Erstellungsverfahren
EE200000530A (et) Faasidetektor
DE69929273D1 (de) Thermisch vernetztes Fluoropolymer
ATE305542T1 (de) Balkenklammer
DE59907300D1 (de) Turbinenschaufel
DE69925447D1 (de) Kühlbare Schaufelblätter
UA3348S (uk) Турбінна лопатка
DE69905837D1 (de) Eine verdunstungsschale
DE59913732D1 (de) Flugkörper
DK1117392T3 (da) Fremgangsmåde til forhindring eller forsinkelse af kateterbaseret revaskularisation
DK1085900T3 (da) Anvendelse af erythropoietin til behandling af primære hæmokromatoser
DE69927776D1 (de) Femurkomponente
DE69929298D1 (de) Beschichtungsvorrichtung
FI981486A0 (fi) Kanavanvaihtomenetelmä
DE69926715D1 (de) Femurkomponente
DE59808832D1 (de) Hochbelastete Turbinenbeschaufelung
FI981830A0 (fi) Terä
DE59708321D1 (de) Innengekühlte Turbomaschinenschaufel
NO982909D0 (no) LÕseanordning for luke eller lignende
DK1091875T3 (da) Pillesikkert eller pillemodstandsdygtigt lukke
DE19980954D2 (de) Wärmebrückenfreier Träger
DK0862671T3 (da) Fremgangsmåde til konservering af papir